Literature DB >> 29185767

Reply to "Comment on 'In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma'".

Ilse R Dubbelboer1, Elsa Lilienberg1, Amar Karalli2,3, Rimma Axelsson2,3, Torkel B Brismar2,3, Charlotte Ebeling Barbier4, Agneta Norén5, Frans Duraj5, Mikael Hedeland6, Ulf Bondesson6, Erik Sjögren1, Per Stål7,8, Rickard Nyman4, Hans Lennernäs1.   

Abstract

Entities:  

Keywords:  Lipiodol; doxorubicin; drug-eluting beads; hepatocelluar carcinoma; image-guided transarterial tumor therapy; interventional radiology; liver cancer; local therapy; transarterial chemoembolization (TACE)

Mesh：

Substances：

Year:  2017        PMID： 29185767     DOI： 10.1021/acs.molpharmaceut.7b00840

Source DB:  PubMed          Journal:  Mol Pharm        ISSN： 1543-8384            Impact factor:   4.939


× No keyword cloud information.
  1 in total

1.  Porcine and Human In Vivo Simulations for Doxorubicin-Containing Formulations Used in Locoregional Hepatocellular Carcinoma Treatment.

Authors:  Ilse R Dubbelboer; Erik Sjögren; Hans Lennernäs
Journal:  AAPS J       Date:  2018-08-30       Impact factor: 4.009
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.